Compare BTQ & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BTQ | EBS |
|---|---|---|
| Founded | 1983 | 1998 |
| Country | Canada | United States |
| Employees | 27 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 448.1M | 411.1M |
| IPO Year | N/A | 2006 |
| Metric | BTQ | EBS |
|---|---|---|
| Price | $3.52 | $8.81 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $10.00 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 2.3M | 711.7K |
| Earning Date | 03-31-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 125.83 |
| EPS | N/A | ★ 0.93 |
| Revenue | N/A | ★ $742,900,000.00 |
| Revenue This Year | $2,332.99 | $1.29 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $9.20 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.09 | $4.45 |
| 52 Week High | $16.00 | $14.06 |
| Indicator | BTQ | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 66.07 | 54.78 |
| Support Level | $2.23 | $7.73 |
| Resistance Level | $3.83 | $9.28 |
| Average True Range (ATR) | 0.30 | 0.31 |
| MACD | 0.17 | 0.15 |
| Stochastic Oscillator | 82.57 | 83.98 |
BTQ Technologies Corp is engaged in the development of computer-based technology related to post-quantum cryptography, particularly as it applies to blockchain and related technologies, and their protection from the emerging security risk of quantum computing. Its products include PQScale, Keelung, Kenting, and Qbyte. PQScale is a novel scaling technique for post-quantum cryptographic primitives. Keelung is a zero-knowledge toolkit for fast, private, and secure applications. Kenting provides acceleration for NIST-compliant post-quantum cryptography, post-quantum zk-SNARKs, and eco-friendly mining hardware, and Qbyte is a quantum risk calculator. Geographically, the company derives maximum revenue from Canada, and also has a presence in Taiwan, and Australia.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.